article_metadata: Niccolò Riccardi Filippo Del Puente Lucia Taramasso Antonio Di Biagio
article_metadata: 10.1177/2325958218821657
article_metadata: J Int Assoc Provid AIDS Care
article_metadata: 2019 Jan-Dec;18:2325958218821657.
article_metadata: dolutegravir dual-therapy optimization rilpivirine
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/30798670/
article_metadata: Anti-HIV Agents / therapeutic use Drug Substitution HIV Infections / drug therapy Sustained Virologic Response Viral Load / drug effects
article_metadata: Anti-HIV Agents / therapeutic use Drug Substitution HIV Infections / drug therapy Sustained Virologic Response Viral Load / drug effects Case Reports Observational Study Adult Aged Drug Therapy, Combination Female HIV-1 / drug effects HIV-1 / genetics Heterocyclic Compounds, 3-Ring / therapeutic use Humans Male Middle Aged Mutation Nitriles Oxazines Piperazines Pyridazines / therapeutic use Pyridones Pyrimidines Raltegravir Potassium / therapeutic use Rilpivirine / therapeutic use Anti-HIV Agents Heterocyclic Compounds, 3-Ring Nitriles Oxazines Piperazines Pyridazines Pyridones Pyrimidines etravirine Raltegravir Potassium dolutegravir Rilpivirine
article_metadata: PMC6748463
article_metadata: 30798670
article_metadata: Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients
article_metadata: 2019